Corcept Therap (CORT.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec30

Corcept Therapeutics' Chief Commercial Officer Exercises 145,000 Share Options

15:02

Dec22

Corcept Therapeutics' Relacorilant Awaits FDA Approval

16:57

Dec4

Corcept Therapeutics Inc Executives Sean Maduck Sold $1.6 Million in Stocks

02:02

Nov6

Corcept Therapeutics CEO Sells 40,000 Shares

08:46

Corcept Therapeutics Incorporated President Disposes of Common Stock

00:57

Nov5

Corcept Therapeutics released FY2025 Q3 earnings on November 4 After-Market (EST), actual revenue USD 207.64 M (forecast USD 218.53 M), actual EPS USD 0.16 (forecast USD 0.135)

00:00

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 207.64 M, Net Income 19.36 M, EPS 0.16

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 194.43 M, Net Income 34.61 M, EPS 0.29

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 157.21 M, Net Income 20.29 M, EPS 0.17

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change